Reviva Pharmaceuticals Holdings Inc (RVPH)
1.89
-0.11
(-5.50%)
USD |
NASDAQ |
Jan 08, 13:21
Reviva Pharmaceuticals Holdings Research and Development Expense (Annual): 31.42M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc | 10.68B |
| Verastem Inc | 61.36M |
| AbbVie Inc | 8.453B |
| Lipocine Inc | -- |
| Applied Therapeutics Inc | 53.90M |